Haplotypic association of DDAH1 with susceptibility to pre-eclampsia
Association between pre-eclampsia (PEE1) and the dimethylarginine dimethylaminohydrolase (DDAH) 1 and 2 genes, which play a role in the regulation of nitric oxide synthesis and release, was studied. In a case–control study design single nucleotide polymorphisms (SNPs) were determined at eight sites...
Saved in:
| Published in | Molecular human reproduction Vol. 11; no. 1; pp. 73 - 77 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Oxford
Oxford University Press
01.01.2005
Oxford Publishing Limited (England) |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1360-9947 1460-2407 1460-2407 |
| DOI | 10.1093/molehr/gah116 |
Cover
| Summary: | Association between pre-eclampsia (PEE1) and the dimethylarginine dimethylaminohydrolase (DDAH) 1 and 2 genes, which play a role in the regulation of nitric oxide synthesis and release, was studied. In a case–control study design single nucleotide polymorphisms (SNPs) were determined at eight sites in the DDAH1 gene and at one site (Pro231Pro) in the DDAH2 gene from 132 women with pre-eclampsia and 112 healthy controls. Three SNPs in the DDAH1 gene were associated with pre-eclampsia, showing complete linkage disequilibrium with each other, but none of the associations in the allele or genotype data reached statistical significance in either of the genes after the correction for multiple testing. Haplotype frequencies were estimated using a population based on a maximum likelihood method (EM algorithm). Four common DDAH1 haplotypes were present and a significant association of haplotypes H2 and H3 with pre-eclampsia (P=0.03) was found. The risk of pre-eclampsia was greatest in individuals (odds ratio: 3.93; 95% confidence interval: 1.54–9.99) who had two copies of the high-risk haplotypes (H2 or H3). The observed haplotypic association provides the first evidence of the importance of DDAH1 polymorphisms in pre-eclampsia susceptibility. |
|---|---|
| Bibliography: | 5To whom correspondence should be addressed at: Research Institute of Public Health, University of Kuopio, P.O.Box 1627, 70211 Kuopio, Finland. Email: jukka.salonen@uku.fi or Email: jukka.salonen@jurilab.com ark:/67375/HXZ-DGLMF45G-X local:gah116 istex:0BE25B93BA3D00B04B72871D66F03D773C403608 href:gah116.pdf ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 |
| ISSN: | 1360-9947 1460-2407 1460-2407 |
| DOI: | 10.1093/molehr/gah116 |